Compare stocks side-by-side
Compare AMGN vs GSK on price performance, valuation, growth and AI ratings.
Compare AMGN, GSK on price performance, valuation, growth and AI ratings. Up to 5 stocks.
| Metric | AMGN | GSK |
|---|---|---|
| Valuation | ||
| Price | $458.55 | $48.31 |
| Market cap | 247.91B | 96.95B |
| P/E | 28.32 | 22.26 |
| EPS | $16.19 | $2.17 |
| Fair value | $599.77 | $71.82 |
| Upside | +30.80% | +48.64% |
| Growth | ||
| Day change | +1.49% | -0.87% |
| 1 month | +8.76% | -1.36% |
| 3 months | +18.86% | -8.53% |
| 6 months | +36.30% | -5.29% |
| Year to date | +40.76% | -0.73% |
| 1 year | +57.91% | +5.99% |
| 5 years | +122.61% | +15.00% |
| Revenue growth | +9.92% | +4.11% |
| Profitability | ||
| Gross margin | +72.65% | +73.52% |
| Operating margin | +33.18% | +23.80% |
| Net margin | +22.93% | +12.97% |
| ROE | +89.32% | +24.64% |
| Dividends | ||
| Dividend yield | +2.17% | +3.76% |
| Payout ratio | +60.45% | +62.01% |
| Stocklytics | ||
| Score | 53.00 | 55.00 |
| Sentiment | Neutral | Neutral |